Product Theater:
Lexicon Pharmaceuticals
WHEN: Thu, Oct 22 // 5:30 pm - 6:30 pm (ET)
IN-PERSON: Seaport Ballroom / Mezzanine / Level 2
LIVESTREAM: TBD
ENDURING: TBD
Beyond the Gradient:
Exploring the Potential of Dual SGLT1 & 2 Inhibition in the Treatment of HCM
This product theater will focus on evaluating the mechanism of dual sodium-glucose cotransporter 1 & 2 inhibition as a novel approach to target myocardial energetics and inflammation in patients with hypertropic cardiomyopathy. An HCM expert will discuss how the dual mechanism may limit oxidative stress and optimize cardiac energy metabolism.
Speaker:
Sharlene Day, MD
University of Philadelphia
BACK TO MAIN PRODUCT THEATERS PAGE